1
Guriq Basi, Jose William Saldanha: Humanized antibodies that recognize beta amyloid peptide. Neuralab, Wyeth, Lahive & Cockfield, Amy E Mandragouras, Debra J Milasincic, February 20, 2007: US07179892 (72 worldwide citation)

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.


2
Guriq Basi, Jose Saldanha: Humanized antibodies that recognize beta amyloid peptide. Elan Pharma International, Wyeth, Lahive & Cockfield, Amy E Mandragouras Esq, Debra J Milasincic Esq, August 14, 2007: US07256273 (60 worldwide citation)

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.


3
Guriq Basi, Jose William Saldanha: Humanized antibodies that recognize beta amyloid peptide. Wyeth, Neuralab, Lahive & Cockfield, Amy E Mandragouras Esq, Debra J Milasincic Esq, March 13, 2007: US07189819 (48 worldwide citation)

The invention provides improves agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.


4
Guriq Basi, Jack Steven Jacobsen: Humanized antibodies that recognize beta amyloid peptide. Janssen Alzheimer Immunotherapy, Townsend and Townsend and Crew, December 1, 2009: US07625560 (31 worldwide citation)

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include antibodies, e.g., humanized antibodies.


5
Guriq Basi, Jose William Saldanha: Humanized antibodies that recognize beta amyloid peptide. Elan Pharma International, Wyeth, Townsend and Townsend and Crew, September 1, 2009: US07582733 (24 worldwide citation)

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.


6
Guriq Basi, Jose Saldanha, Frédérique Bard: Humanized antibodies that recognize beta amyloid peptide. Janssen Alzheimer Immunotherapy, Wyeth, Alston and Bird, January 18, 2011: US07871615 (14 worldwide citation)

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include antibodies, e.g., humanized antibodies.


7
Guriq Basi, Jose William Saldanha, Dale B Schenk: Humanized antibodies that recognize β-amyloid peptide. Janssen Alzheimer Immunotherapy, Wyeth, Townsend and Townsend and Crew, April 20, 2010: US07700751 (11 worldwide citation)

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.


8
Guriq Basi, Jose Saldanha: Humanized antibodies that recognize beta amyloid peptide. Wyeth, Janssen Alzheimer Immunotherapy, Alston and Bird, March 6, 2012: US08128928 (6 worldwide citation)

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.


9
Guriq Basi, Jose Saldanha, Ted Yednock: Humanized antibodies that recognize beta amyloid peptide. Elan Pharmaceuticals, Lahive & Cockfield, September 4, 2003: US20030165496-A1 (2 worldwide citation)

The invention provides improves agents and methods for treatment of diseases associated with amyloid deposits of A in the brain of a patient. Preferred agents include humanized antibodies.


10
Guriq Basi, Jack Steven Jacobsen: Humanized Aβ antibodies for use in improving cognition. Janssen Alzheimer Immunotherapy, Wyeth, Alston & Bird, December 23, 2014: US08916165

The invention provides improved agents and methods for treatment of diseases associated with beta amyloid (Aβ). Preferred agents include antibodies, e.g., humanized antibodies specific for Aβ.